Cephalon sales rise, but fall short of estimates; RoActemra wins new use in Europe;

@FiercePharma: Wockhardt finally unloads nutrition unit to Danone. French giant also said to be eyeing Pfizer's nutrition biz. Story | Follow @FiercePharma

> Cephalon sales lagged analyst estimates while costs rose as revenues from its narcolepsy drug Provigil dropped by 5%. More

> Roche's RoActemra won European approval for use in children with Systemic Juvenile Idiopathic Arthritis, a rare and serious form of the disease. Story

> Pfizer's Sutent is prescribed by virtually all U.S. doctors treating kidney cancer, with Bayer's Nexavar used by 89%. Release

> Regulators pronounced success with a joint inspection pilot program uniting the FDA, the European Medicines Agency, and regulators in Australia, France, Germany, Ireland and more. Report

> Impax Laboratories profits sank by 60% as it lost exclusivity in the market for generic Flomax, a prostate drug. Piece

> Generics maker Akorn posted a $17.9 million Q2 profit and agreed to buy a stake in eye drug specialist Aciex Therapeutics. Item

> Agvar Chemicals founder Agnes Varis, a leading figure in the generics industry and access-to-generics advocate, has died at 81. News

Biotech News

@FierceBiotech: Insmed shares crater as FDA puts a clamp on Ph3 CF study. Report | Follow @FierceBiotech

@JohnCFierce: Sometimes wonder when/if a Big Pharma would do a Valeant, punt early-stage research, pick up good stuff after PoC. Pfizer? | Follow @JohnCFierce

@RyanMFierce: BioClinica 2Q earnings out, service revenue up 8.7% News $BIOC | Follow @RyanMFierce

@MaureenFierce: Which 3 Pharmas are tops for cardiology meds? $PFE is one, according to doctors. Article #sermosurveys | Follow @MaureenFierce

> AMAG investor out to derail Allos merger with buyout offer. More

> Vectura gains mystery partner for VR315 lung drug. Article

> SEC lays out "tall tales" in $20M biotech securities scam. Report

> Merck scores promising pivotal data on allergy treatment. News

> A drug development revolutionary advocates radical change in R&D. Story

> Celgene tackles anemia in $242M development pact with Acceleron. More

Drug Delivery News

> More companies going with prefilled syringes ahead of flu season. Item

> Growth factor delivery method makes long-lasting blood vessels. More

> Pfizer completes sale of Capsugel delivery unit. Report

> OctoPlus tries to get drug-delivery tentacles into generics. Story

> Nanomaterial improves on VEGF for blood-vessel growth. News

> Depomed inks another deal for AcuForm, this time with Ironwood. Article

Medical Device News

> FMD speaks with Cell>Point's David Rollo. Item

> Berlin Heart pediatric offering could soon help U.S. patents. Piece

> Restoration Robotics raises $41M. Story

> BD, Lab21 team on Aspergillus assay. News

> Fresenius buys U.S. competitors. Article

> Ellipse Technologies completes $17.6M Series C financing. More

> Becton Dickson sees strong Q3. Report

And Finally... Dark chocolate plus exercise equals healthier muscles, mouse study finds. Report

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…